Carcinoid disease
- 1 March 1997
- journal article
- review article
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 40 (3) , 349-362
- https://doi.org/10.1007/bf02050428
Abstract
Carcinoid syndrome is the product of a rare but fascinating malignant neoplasm. Carcinoid syndrome was described more than 100 years ago, and recent advances in diagnostic localization, elucidation of the mechanisms of oncogenesis, treatment options, and, consequently, patient prognosis have been made. Current modalities of treatment, possible therapeutic implications of new avenues of research, and current literature on the chemotherapeutic combinations used are reviewed.Keywords
This publication has 129 references indexed in Scilit:
- Per operative localization of a carcinoid tumour of the breast using indium-111 pentetreotide and a nuclear surgical probeEuropean Journal of Nuclear Medicine and Molecular Imaging, 1995
- Interferon Treatment in Patients with Malignant CarcinoidsActa Oncologica, 1989
- Percutaneous Ultrasonography-guided Cutting Biopsy from Liver Metastases of Endocrine Gastrointestinal TumorsAnnals of Surgery, 1987
- SomatostatinNew England Journal of Medicine, 1983
- Role of hepatic arterial embolisation in the carcinoid syndrome.BMJ, 1983
- Effects of Leukocyte Interferon on Clinical Symptoms and Hormone Levels in Patients with Mid-Gut Carcinoid Tumors and Carcinoid SyndromeNew England Journal of Medicine, 1983
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980
- Blockade of the Flush Associated with Metastatic Gastric Carcinoid by Combined Histamine H1and H2Receptor AntagonistsNew England Journal of Medicine, 1979
- The Carcinoid FlushNew England Journal of Medicine, 1978
- Somatostatin inhibits adrenergic and cholinergic neurotransmission in smooth muscleLife Sciences, 1978